Stryker Corporation Recalls MOLLI 2 System Components Over Marker Dislodgement Risk
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Stryker Corporation is recalling 5,864 units of the MOLLI 2 System to update product labeling after reports of magnetized surgical tools dislodging markers during medical procedures.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on March 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, Devices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Stryker Corporation has initiated a voluntary recall of the MOLLI 2 System due to a necessary update to the product's Instructions for Use (IFU). The recall was prompted by findings that magnetized surgical tools can dislodge markers while they are being used during target tissue removal procedures. The MOLLI Marker is designed to be placed in soft tissue to temporarily mark a surgical site for removal.
Which Products Are Affected
A total of 5,864 units are affected by this recall. The MOLLI 2 System components include:
- MOLLI Introducer (8cm, 14G) and MOLLI Marker: Catalog Number MM1000 (Pack of 10), UDI (GTIN) 00850024195028.
- MOLLI Introducer (12cm, 14G) and MOLLI Marker: Catalog Number MS-00009 (Pack of 10), UDI (GTIN) 00850024195134.
- MOLLI 2 Wand: Catalog Number MP2001, UDI (GTIN) 00850024195141.
- MOLLI OncoPen: Catalog Number MP2015A, UDI (GTIN) 00850024195219.
- MOLLI 2 Tablet: Catalog Number MT2001, UDI (GTIN) 00850024195158.
Distribution was worldwide, including nationwide across 47 U.S. states and the District of Columbia, as well as Canada, Singapore, Panama, Jamaica, and the Cayman Islands.
What You Should Do
Stryker Corporation initiated the recall by sending notification letters to affected customers starting January 21, 2026. Healthcare providers and facilities using the MOLLI 2 System should review the updated Instructions for Use (IFU) provided by the firm to ensure surgical tools do not inadvertently dislodge markers during procedures.
Why This Matters
This recall is significant because the unintended movement or dislodgement of a surgical marker during tissue removal could lead to inaccuracies during surgery or the failure to remove the intended target tissue. The FDA has classified this as a Class II recall.
Source
Recall information provided by the FDA under Recall Number Z-1427-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category